CM
CLVS

Caption Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Caption Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-187,500
Closed -$1.09M – 1911
2021
Q2 		$1.09M Buy
+187,500
New +$1.1M 0.01% 872
2020
Q2 		– Sell
-104,000
Closed -$662K – 1245
2020
Q1 		$662K Sell
104,000
-220,000
-68% -$1.76M 0.04% 492
2019
Q4 		$3.38M Sell
324,000
-126,500
-28% -$920K 0.11% 248
2019
Q3 		$1.77M Buy
450,500
+390,500
+651% +$3.16M 0.09% 266
2019
Q2 		$892K Sell
60,000
-84,100
-58% -$1.52M 0.04% 392
2019
Q1 		$3.58M Buy
+144,100
New +$3.61M 0.2% 144

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Caption Management's CLVS Position: Q3 2022 in Review

Caption Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 182,455 shares — an estimated $328K sold.

Caption Management first reported a position in CLVS in Q3 2018 and held it in 7 quarters. The position peaked at $892K in Q2 2019. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • Caption Management reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • Caption Management sold 182,455 Clovis Oncology, Inc. shares in Q3 2022, an estimated $328K.
  • Caption Management first reported a position in Clovis Oncology, Inc. in Q3 2018 and held it in 7 quarters.
  • Caption Management's Clovis Oncology, Inc. position peaked at $892K in Q2 2019.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Caption Management's 13F filing for Q3 2022, filed 14 Nov 2022.